A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol.

Lin-Rui GaoXin WangWeiming HanWei DengChen LiXiaomin WangYidian ZhaoWenjie NiXiao ChangZongmei ZhouLei DengWenqing WangWenyang LiuJun LiangTao ZhangNan BiJianyang WangYirui ZhaiQinfu FengJima LvLing LiZefen Xiao

Published in: BMC cancer (2020)

clinicaltrials.gov ( NCT03308552 , November 1, 2017).

Keyphrases

phase iii
locally advanced
double blind
open label
study protocol
clinical trial
placebo controlled
rectal cancer
squamous cell carcinoma
randomized controlled trial
radiation therapy
phase ii
early stage
cross sectional